Table 1 Sequence of systemic therapies administered since diagnosis of cutaneous T-cell lymphoma/ Sézary Syndrome
Prior therapy for CTCL/SS | Sequence and Duration | |
|---|---|---|
Photochemotherapy (PUVA) | First Line of Therapy | 8 months (2009) |
Photopheresis | Second Line of Therapy | 31 months (2009–2012) |
Romidepsin | Third Line of Therapy | 48 months (2010–2014) |
Pegylated liposomal doxorubicin | Fourth Line of Therapy | 3 months (2014) |
Gemcitabine | Fifth Line of Therapy | 1 month (2014) |
Alemtuzumab | Sixth Line of Therapy | 2 months (2015) |
Mogamulizumab | Seventh Line of Therapy | 1 month (2015) |
Total skin electron beam therapy | Eighth Line of Therapy | 3 months (2016) |
Bexarotene | Ninth Line of Therapy | 2 months (2016) |
Pralatrexate | Tenth Line of Therapy | 2 months (2016) |
ICE (Ifosfamide, Carboplatin, Etoposide) | Eleventh Line of Therapy | 3 months (2016–2017) |
Sibling allogenic stem cell transplantation | Twelfth Line of Therapy | (2017) |